Troendle August J.
President & CEO
Troendle August J. has filed 20 SEC Form 4 filings (37 transaction rows) across 1 company, with disclosures dating back to 2025. 19 of those filings fall inside the rolling window. Most recent filing: Sep 25, 2026.
On the most recent filing, Troendle August J. is listed as President & CEO at Medpace Holdings, Inc. Inside the rolling window, Troendle August J. reported no open-market purchases and 35 open-market sales totaling $326.5M in MEDP. The largest disclosed transaction in the window is a sale of 59,025 MEDP shares on Nov 24, 2025, worth $35.9M.
Companies traded
Other insiders at MEDP
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$326.5M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| MEDP | President & CEO | Sale | 16,083 | $10.1M | Sep 25 | SEC ↗ | |
| MEDP | President & CEO | Sale | 27,833 | $17.3M | Sep 25 | SEC ↗ | |
| MEDP | President & CEO | Sale | 21,883 | $13.6M | Sep 23 | SEC ↗ | |
| MEDP | President & CEO | Sale | 49,018 | $30.8M | Sep 23 | SEC ↗ | |
| MEDP | President & CEO | Sale | 10,880 | $6.7M | Sep 21 | SEC ↗ | |
| MEDP | President & CEO | Sale | 15,971 | $9.9M | Sep 17 | SEC ↗ | |
| MEDP | President & CEO | Sale | 8,770 | $5.4M | Sep 17 | SEC ↗ | |
| MEDP | President & CEO | Sale | 650 | $403K | Aug 31 | SEC ↗ | |
| MEDP | President & CEO | Sale | 673 | $418K | Aug 27 | SEC ↗ | |
| MEDP | President & CEO | Sale | 4,000 | $2.5M | Aug 27 | SEC ↗ | |
| MEDP | President & CEO | Sale | 13,995 | $8.7M | Aug 25 | SEC ↗ | |
| MEDP | President & CEO | Sale | 1,983 | $1.2M | Aug 25 | SEC ↗ | |
| MEDP | President & CEO | Sale | 15,609 | $9.5M | Aug 21 | SEC ↗ | |
| MEDP | President & CEO | Sale | 27,174 | $16.8M | Aug 21 | SEC ↗ | |
| MEDP | President & CEO | Sale | 11,366 | $6.8M | Aug 14 | SEC ↗ | |
| MEDP | President & CEO | Sale | 458 | $275K | Aug 14 | SEC ↗ | |
| MEDP | President & CEO | Sale | 5,534 | $3.3M | Aug 12 | SEC ↗ | |
| MEDP | President & CEO | Sale | 17,610 | $10.7M | Aug 12 | SEC ↗ | |
| MEDP | President & CEO | Sale | 3,728 | $2.2M | Jul 29 | SEC ↗ | |
| MEDP | President & CEO | Sale | 3,510 | $2.1M | Jul 29 | SEC ↗ | |
| MEDP | CEO | Sale | 668 | $395K | Dec 4 | SEC ↗ | |
| MEDP | CEO | Sale | 23,178 | $13.8M | Dec 3 | SEC ↗ | |
| MEDP | CEO | Sale | 5,698 | $3.4M | Dec 3 | SEC ↗ | |
| MEDP | CEO | Sale | 41,331 | $25.1M | Dec 1 | SEC ↗ | |
| MEDP | CEO | Sale | 15,151 | $9.0M | Dec 1 | SEC ↗ |
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has Troendle August J. made?
Troendle August J. has filed 20 SEC Form 4 filings (37 transaction rows) across 1 company since 2025.
Which companies does Troendle August J. trade?
Troendle August J. has filed SEC Form 4 disclosures for 1 company, including MEDP.
When was Troendle August J.'s most recent SEC Form 4 filing?
Troendle August J.'s most recent SEC Form 4 filing on Tracefour is dated Sep 25, 2026.
What is Troendle August J.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Troendle August J. is listed as President & CEO.
What is Troendle August J.'s total buy and sell value in the current window?
Inside the rolling retention window, Troendle August J. bought $0 and sold $326.5M based on SEC Form 4 filings.
What was Troendle August J.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 59,025 MEDP shares on 2025-11-24, worth $35.9M, per SEC Form 4 filings.